About Applied Therapeutics
Applied Therapeutics is a company based in New York (United States) founded in 2015 was acquired by Cycle Pharma in December 2025.. Applied Therapeutics has raised $65.16 million across 7 funding rounds from investors including ARE, Cycle Pharma and Syno Capital. The company has 35 employees as of December 31, 2024. Applied Therapeutics offers products and services including Govorestat and AT-001. Applied Therapeutics operates in a competitive market with competitors including Tenaya Therapeutics, Cellino, MyoKardia, Eiger BioPharmaceuticals and Arrakis Therapeutics, among others.
- Headquarter New York, United States
- Employees 35 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Applied Therapeutics, Inc.
-
Annual Revenue
$455 K-95.45as on Dec 31, 2024
-
Net Profit
$-105.62 M11.81as on Dec 31, 2024
-
EBITDA
$-103.87 M-61.84as on Dec 31, 2024
-
Total Equity Funding
$65.16 M (USD)
in 7 rounds
-
Latest Funding Round
$100 M (USD), Post-IPO
Feb 27, 2024
-
Investors
ARE
& 4 more
-
Employee Count
35
as on Dec 31, 2024
-
Acquired by
Cycle Pharma
(Dec 11, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Applied Therapeutics
Applied Therapeutics is a publicly listed company on the NASDAQ with ticker symbol APLT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Applied Therapeutics
Applied Therapeutics offers a comprehensive portfolio of products and services, including Govorestat and AT-001. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug targeting rare metabolic disorders for patient treatment.
Potential therapy for rare conditions in clinical development.
Unlock access to complete
Unlock access to complete
Funding Insights of Applied Therapeutics
Applied Therapeutics has successfully raised a total of $65.16M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $100 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $100.0M
-
First Round
First Round
(08 Feb 2017)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Post-IPO - Applied Therapeutics | Valuation |
investors |
|
| May, 2023 | Amount | Post-IPO - Applied Therapeutics | Valuation |
investors |
|
| Nov, 2019 | Amount | Post-IPO - Applied Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Applied Therapeutics
Applied Therapeutics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Cycle Pharma and Syno Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Syno Capital is focused on healthcare investment and innovation.
|
Founded Year | Domain | Location | |
|
US private equity investments are managed by E Squared Capital.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Applied Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Applied Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Applied Therapeutics Comparisons
Competitors of Applied Therapeutics
Applied Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tenaya Therapeutics, Cellino, MyoKardia, Eiger BioPharmaceuticals and Arrakis Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Specialized drugs are developed for genetic heart diseases.
|
|
| domain | founded_year | HQ Location |
Developer of antiviral agents against targets in the treatment of hepatitis
|
|
| domain | founded_year | HQ Location |
Provider of tools for the analysis of RNA structures
|
|
| domain | founded_year | HQ Location |
Therapeutics for heart and cardiovascular diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Applied Therapeutics
Frequently Asked Questions about Applied Therapeutics
When was Applied Therapeutics founded?
Applied Therapeutics was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Applied Therapeutics located?
Applied Therapeutics is headquartered in New York, United States. It is registered at New York, New York, United States.
Is Applied Therapeutics a funded company?
Applied Therapeutics is a funded company, having raised a total of $65.16M across 7 funding rounds to date. The company's 1st funding round was a Post-IPO of $20.01M, raised on Feb 08, 2017.
How many employees does Applied Therapeutics have?
As of Dec 31, 2024, the latest employee count at Applied Therapeutics is 35.
What is the annual revenue of Applied Therapeutics?
Annual revenue of Applied Therapeutics is $455K as on Dec 31, 2024.
What does Applied Therapeutics do?
Applied Therapeutics was founded in 2015 and is headquartered in New York, United States. Focus is placed on the development of novel drugs targeting metabolic and cardiovascular diseases within the biotechnology sector. Proprietary technology, licensed from Dr. Donald Landrys laboratory at Columbia University, is applied to enzymes previously linked to these conditions but unsuccessful in prior therapies. Operations center on advancing these targets toward clinical applications.
Who are the top competitors of Applied Therapeutics?
Applied Therapeutics's top competitors include Esperion Therapeutics, Tenaya Therapeutics and Cellino.
What products or services does Applied Therapeutics offer?
Applied Therapeutics offers Govorestat and AT-001.
Is Applied Therapeutics publicly traded?
Yes, Applied Therapeutics is publicly traded on NASDAQ under the ticker symbol APLT.
Who are Applied Therapeutics's investors?
Applied Therapeutics has 5 investors. Key investors include ARE, Cycle Pharma, Syno Capital, E Squared Capital, and ETP Global Fund.
What is Applied Therapeutics's ticker symbol?
The ticker symbol of Applied Therapeutics is APLT on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.